Stericycle (SRCL) Downgraded by Robert W. Baird to Underperform

Share on StockTwits

Robert W. Baird lowered shares of Stericycle (NASDAQ:SRCL) from a neutral rating to an underperform rating in a research note issued to investors on Wednesday morning, Benzinga reports. They currently have $44.00 price objective on the business services provider’s stock.

A number of other brokerages have also recently issued reports on SRCL. BMO Capital Markets boosted their target price on Stericycle from $41.00 to $45.00 and gave the stock a market perform rating in a report on Monday, March 4th. Barrington Research decreased their target price on Stericycle from $64.00 to $55.00 and set an outperform rating for the company in a report on Monday, March 11th. Zacks Investment Research cut Stericycle from a hold rating to a sell rating in a report on Friday, February 15th. Goldman Sachs Group upgraded Stericycle from a neutral rating to a buy rating and set a $66.00 target price for the company in a report on Friday, March 1st. Finally, BidaskClub upgraded Stericycle from a sell rating to a hold rating in a report on Tuesday, March 26th. Three analysts have rated the stock with a sell rating, three have assigned a hold rating and four have issued a buy rating to the company. The stock has an average rating of Hold and an average target price of $59.00.

Shares of NASDAQ:SRCL opened at $56.04 on Wednesday. The company has a debt-to-equity ratio of 1.03, a current ratio of 1.02 and a quick ratio of 1.02. Stericycle has a 1 year low of $34.36 and a 1 year high of $71.43. The stock has a market cap of $5.09 billion, a PE ratio of 12.59, a PEG ratio of 2.09 and a beta of 1.09.

Stericycle (NASDAQ:SRCL) last issued its earnings results on Thursday, February 28th. The business services provider reported $1.03 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.96 by $0.07. Stericycle had a positive return on equity of 14.19% and a negative net margin of 7.02%. The business had revenue of $852.70 million during the quarter, compared to analysts’ expectations of $848.75 million. As a group, sell-side analysts forecast that Stericycle will post 3.53 EPS for the current year.

In other Stericycle news, Director Mark C. Miller sold 260,314 shares of the company’s stock in a transaction that occurred on Tuesday, April 9th. The stock was sold at an average price of $57.18, for a total value of $14,884,754.52. Following the completion of the transaction, the director now owns 325,848 shares in the company, valued at approximately $18,631,988.64. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 3.50% of the stock is owned by corporate insiders.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. JOYN Advisors Inc. boosted its holdings in Stericycle by 1,253.7% in the 4th quarter. JOYN Advisors Inc. now owns 731 shares of the business services provider’s stock worth $27,000 after acquiring an additional 677 shares during the period. Bronfman E.L. Rothschild L.P. boosted its holdings in Stericycle by 159.5% in the 4th quarter. Bronfman E.L. Rothschild L.P. now owns 807 shares of the business services provider’s stock worth $30,000 after acquiring an additional 496 shares during the period. Pearl River Capital LLC purchased a new position in Stericycle in the 4th quarter worth approximately $41,000. Oregon Public Employees Retirement Fund boosted its holdings in Stericycle by 6,998.9% in the 4th quarter. Oregon Public Employees Retirement Fund now owns 1,638,209 shares of the business services provider’s stock worth $45,000 after acquiring an additional 1,615,132 shares during the period. Finally, North Star Investment Management Corp. boosted its holdings in Stericycle by 667.5% in the 1st quarter. North Star Investment Management Corp. now owns 1,535 shares of the business services provider’s stock worth $84,000 after acquiring an additional 1,335 shares during the period. Hedge funds and other institutional investors own 96.52% of the company’s stock.

Stericycle Company Profile

Stericycle, Inc, together with its subsidiaries, provides regulated and compliance solutions to the healthcare, retail, and commercial businesses in the United States and internationally. It operates through three segments: Domestic and Canada Regulated Waste and Compliance; International Regulated Waste and Compliance; and Domestic Communication and Related Services.

Recommended Story: Risk Tolerance and Your Investment Decisions

Analyst Recommendations for Stericycle (NASDAQ:SRCL)

Receive News & Ratings for Stericycle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle and related companies with MarketBeat.com's FREE daily email newsletter.